Disperazol Partners with CC4CARB

We are proud to have been selected by CC4CARB (https://www.cc4carb-collection.org/) to support the development of our next generation compounds to reduce cyclic-di-GMP levels in Gram-negative bacteria.

This collaboration will allow Disperazol to accelerate our product development into species beyond Pseudomonas aeruginosa.